About
Addex Therapeutics is a clinical-stage pharmaceutical company developing orally available small-molecule allosteric modulators targeted at neurological disorders such as post-stroke recovery, substance use disorder, and chronic cough.
Explore Addex Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.